nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—Nortriptyline—ADRA1D—polycystic ovary syndrome	0.0103	0.0765	CrCbGaD
Cyclobenzaprine—Doxepin—ADRA1D—polycystic ovary syndrome	0.00922	0.0687	CrCbGaD
Cyclobenzaprine—CYP1A2—urine—polycystic ovary syndrome	0.00916	0.218	CbGeAlD
Cyclobenzaprine—Nortriptyline—ADRA1B—polycystic ovary syndrome	0.00877	0.0653	CrCbGaD
Cyclobenzaprine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.00826	0.0615	CrCbGaD
Cyclobenzaprine—Promazine—ADRA1D—polycystic ovary syndrome	0.0082	0.061	CrCbGaD
Cyclobenzaprine—Doxepin—ADRA1B—polycystic ovary syndrome	0.00787	0.0586	CrCbGaD
Cyclobenzaprine—Imipramine—ADRA1D—polycystic ovary syndrome	0.00718	0.0534	CrCbGaD
Cyclobenzaprine—HTR2A—urine—polycystic ovary syndrome	0.00717	0.17	CbGeAlD
Cyclobenzaprine—Amitriptyline—ADRA1D—polycystic ovary syndrome	0.00713	0.0531	CrCbGaD
Cyclobenzaprine—Promazine—ADRA1B—polycystic ovary syndrome	0.00699	0.0521	CrCbGaD
Cyclobenzaprine—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00681	0.0507	CrCbGaD
Cyclobenzaprine—CYP3A4—urine—polycystic ovary syndrome	0.00663	0.158	CbGeAlD
Cyclobenzaprine—CYP2D6—urine—polycystic ovary syndrome	0.00653	0.155	CbGeAlD
Cyclobenzaprine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00612	0.0456	CrCbGaD
Cyclobenzaprine—Amitriptyline—ADRA1B—polycystic ovary syndrome	0.00609	0.0453	CrCbGaD
Cyclobenzaprine—Nortriptyline—ADRA1A—polycystic ovary syndrome	0.0059	0.0439	CrCbGaD
Cyclobenzaprine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.00556	0.0414	CrCbGaD
Cyclobenzaprine—Promethazine—ADRA1A—polycystic ovary syndrome	0.00535	0.0398	CrCbGaD
Cyclobenzaprine—Doxepin—ADRA1A—polycystic ovary syndrome	0.0053	0.0394	CrCbGaD
Cyclobenzaprine—Promazine—ADRA1A—polycystic ovary syndrome	0.00471	0.035	CrCbGaD
Cyclobenzaprine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00427	0.0372	CcSEcCtD
Cyclobenzaprine—Imipramine—ADRA1A—polycystic ovary syndrome	0.00412	0.0307	CrCbGaD
Cyclobenzaprine—Amitriptyline—ADRA1A—polycystic ovary syndrome	0.0041	0.0305	CrCbGaD
Cyclobenzaprine—Drowsiness—Metformin—polycystic ovary syndrome	0.0041	0.0357	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00402	0.035	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP19A1—polycystic ovary syndrome	0.00368	0.0274	CrCbGaD
Cyclobenzaprine—Hepatitis—Metformin—polycystic ovary syndrome	0.00368	0.032	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00366	0.0319	CcSEcCtD
Cyclobenzaprine—Flatulence—Metformin—polycystic ovary syndrome	0.00315	0.0275	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00313	0.0273	CcSEcCtD
Cyclobenzaprine—Vision blurred—Metformin—polycystic ovary syndrome	0.00302	0.0263	CcSEcCtD
Cyclobenzaprine—Tremor—Metformin—polycystic ovary syndrome	0.003	0.0261	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00297	0.0259	CcSEcCtD
Cyclobenzaprine—Malaise—Metformin—polycystic ovary syndrome	0.00289	0.0252	CcSEcCtD
Cyclobenzaprine—Syncope—Metformin—polycystic ovary syndrome	0.00287	0.025	CcSEcCtD
Cyclobenzaprine—Palpitations—Metformin—polycystic ovary syndrome	0.00283	0.0247	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00281	0.0245	CcSEcCtD
Cyclobenzaprine—Hypertension—Metformin—polycystic ovary syndrome	0.00276	0.0241	CcSEcCtD
Cyclobenzaprine—Chest pain—Metformin—polycystic ovary syndrome	0.00273	0.0238	CcSEcCtD
Cyclobenzaprine—Myalgia—Metformin—polycystic ovary syndrome	0.00273	0.0238	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP1A1—polycystic ovary syndrome	0.00271	0.0202	CrCbGaD
Cyclobenzaprine—Discomfort—Metformin—polycystic ovary syndrome	0.00269	0.0235	CcSEcCtD
Cyclobenzaprine—Oedema—Metformin—polycystic ovary syndrome	0.00261	0.0228	CcSEcCtD
Cyclobenzaprine—Shock—Metformin—polycystic ovary syndrome	0.00257	0.0224	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00256	0.0223	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00253	0.022	CcSEcCtD
Cyclobenzaprine—Anorexia—Metformin—polycystic ovary syndrome	0.00249	0.0217	CcSEcCtD
Cyclobenzaprine—Hypotension—Metformin—polycystic ovary syndrome	0.00244	0.0213	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00238	0.0207	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00235	0.0204	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00233	0.0203	CcSEcCtD
Cyclobenzaprine—Somnolence—Metformin—polycystic ovary syndrome	0.00232	0.0202	CcSEcCtD
Cyclobenzaprine—HTR2A—embryo—polycystic ovary syndrome	0.00232	0.0551	CbGeAlD
Cyclobenzaprine—Dyspepsia—Metformin—polycystic ovary syndrome	0.0023	0.02	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00227	0.0198	CcSEcCtD
Cyclobenzaprine—Fatigue—Metformin—polycystic ovary syndrome	0.00225	0.0196	CcSEcCtD
Cyclobenzaprine—Constipation—Metformin—polycystic ovary syndrome	0.00223	0.0195	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00215	0.0188	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00214	0.0186	CcSEcCtD
Cyclobenzaprine—Urticaria—Metformin—polycystic ovary syndrome	0.00208	0.0181	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00207	0.018	CcSEcCtD
Cyclobenzaprine—Asthenia—Metformin—polycystic ovary syndrome	0.00187	0.0163	CcSEcCtD
Cyclobenzaprine—Pruritus—Metformin—polycystic ovary syndrome	0.00185	0.0161	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00179	0.0156	CcSEcCtD
Cyclobenzaprine—Dizziness—Metformin—polycystic ovary syndrome	0.00173	0.0151	CcSEcCtD
Cyclobenzaprine—Vomiting—Metformin—polycystic ovary syndrome	0.00166	0.0145	CcSEcCtD
Cyclobenzaprine—Rash—Metformin—polycystic ovary syndrome	0.00165	0.0144	CcSEcCtD
Cyclobenzaprine—Dermatitis—Metformin—polycystic ovary syndrome	0.00165	0.0143	CcSEcCtD
Cyclobenzaprine—Headache—Metformin—polycystic ovary syndrome	0.00164	0.0143	CcSEcCtD
Cyclobenzaprine—Nausea—Metformin—polycystic ovary syndrome	0.00155	0.0135	CcSEcCtD
Cyclobenzaprine—HTR2A—pituitary gland—polycystic ovary syndrome	0.00153	0.0365	CbGeAlD
Cyclobenzaprine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00152	0.0361	CbGeAlD
Cyclobenzaprine—HTR2A—adrenal gland—polycystic ovary syndrome	0.00137	0.0326	CbGeAlD
Cyclobenzaprine—HTR2A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00136	0.00192	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00135	0.00191	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00135	0.00191	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00135	0.00191	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00134	0.00189	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00134	0.00189	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00133	0.00187	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00133	0.00187	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00132	0.00186	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00131	0.00185	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00128	0.00181	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00127	0.0018	CbGpPWpGaD
Cyclobenzaprine—HTR2A—vagina—polycystic ovary syndrome	0.00127	0.0302	CbGeAlD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00126	0.00178	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00125	0.00176	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00123	0.00174	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00123	0.00173	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00123	0.00173	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00123	0.00173	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00123	0.00173	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00119	0.00168	CbGpPWpGaD
Cyclobenzaprine—HTR2A—endocrine gland—polycystic ovary syndrome	0.00119	0.0283	CbGeAlD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00117	0.00165	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00116	0.00164	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—female gonad—polycystic ovary syndrome	0.00116	0.0277	CbGeAlD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00116	0.00164	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00115	0.00162	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00115	0.00162	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00111	0.00157	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0011	0.0262	CbGeAlD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00109	0.00154	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00109	0.00154	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00109	0.00153	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00109	0.00153	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00108	0.00153	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00108	0.0257	CbGeAlD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00108	0.00152	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00107	0.00152	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00107	0.00151	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00106	0.00149	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00106	0.00149	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00104	0.00147	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.001	0.00142	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000998	0.00141	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000993	0.0014	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000991	0.0014	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000989	0.00139	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000986	0.00139	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000965	0.00136	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000952	0.00134	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00092	0.0013	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000907	0.00128	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000904	0.00128	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000899	0.00127	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000898	0.00127	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000897	0.00127	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000887	0.00125	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000885	0.00125	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000875	0.00123	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00087	0.00123	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NPB—polycystic ovary syndrome	0.000868	0.00122	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000863	0.00122	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00086	0.00121	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000841	0.00119	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000841	0.00119	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000832	0.00117	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000821	0.00116	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000806	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000803	0.00113	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000802	0.00113	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00079	0.00112	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000785	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000781	0.0011	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000771	0.00109	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.00077	0.00109	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000769	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000763	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000748	0.00105	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000742	0.00105	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000732	0.00103	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000731	0.00103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000725	0.00102	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000725	0.00102	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00071	0.001	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000704	0.000993	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000704	0.000993	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.0007	0.000988	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000698	0.000985	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000682	0.000963	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000682	0.000962	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000678	0.000956	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000658	0.000928	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000655	0.000924	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000653	0.000921	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000652	0.00092	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00064	0.000903	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000624	0.00088	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000622	0.000878	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000608	0.000858	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000597	0.000842	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000597	0.000842	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000589	0.000831	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000582	0.000821	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000572	0.000807	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000568	0.000801	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000564	0.000796	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000557	0.000785	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000557	0.000785	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000555	0.000782	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000553	0.00078	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000542	0.000765	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00053	0.000748	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000519	0.000733	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000517	0.00073	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000516	0.000727	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000506	0.000714	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000503	0.00071	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000499	0.000703	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000485	0.000684	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00048	0.000677	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000473	0.000667	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000472	0.000665	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000472	0.000665	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00047	0.000663	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000467	0.000659	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000466	0.000658	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000461	0.000651	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00046	0.000649	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00046	0.000649	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000453	0.00064	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000451	0.000636	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000446	0.00063	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000442	0.000624	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000437	0.000616	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000436	0.000615	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000432	0.00061	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000428	0.000604	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000427	0.000602	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000427	0.000602	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000422	0.000595	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000412	0.000582	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000405	0.000572	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000402	0.000567	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.0004	0.000565	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000396	0.000558	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000395	0.000557	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000376	0.00053	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000375	0.000529	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000375	0.000528	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00037	0.000522	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000364	0.000513	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000364	0.000513	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000359	0.000506	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000357	0.000504	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000354	0.000499	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000353	0.000498	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000336	0.000474	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000331	0.000467	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000328	0.000462	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000327	0.000461	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.00032	0.000451	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000319	0.000449	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.00031	0.000437	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000305	0.00043	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000305	0.00043	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000305	0.00043	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000304	0.000429	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.0003	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000293	0.000414	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000291	0.00041	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000289	0.000408	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000285	0.000402	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000285	0.000402	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000283	0.0004	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000282	0.000398	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000277	0.000391	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000276	0.000389	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000276	0.000389	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000271	0.000382	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000268	0.000378	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000266	0.000376	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000266	0.000375	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000266	0.000375	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000262	0.00037	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000256	0.000361	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000256	0.000361	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000252	0.000356	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000252	0.000356	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000246	0.000347	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000241	0.000341	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000238	0.000336	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000235	0.000331	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000235	0.000331	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000234	0.00033	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000234	0.00033	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000225	0.000318	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000223	0.000314	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000219	0.000308	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000217	0.000305	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000215	0.000304	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000214	0.000302	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000214	0.000302	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000212	0.000299	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000209	0.000295	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.000203	0.000286	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000202	0.000286	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000202	0.000285	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000199	0.00028	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000198	0.000279	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000187	0.000264	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000186	0.000263	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000186	0.000262	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000183	0.000259	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.00018	0.000255	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000174	0.000245	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	0.000172	0.000243	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000167	0.000236	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000167	0.000236	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	0.000166	0.000234	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000165	0.000233	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000163	0.000231	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	0.000158	0.000223	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000157	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000157	0.000222	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	0.000157	0.000221	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000156	0.00022	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000153	0.000216	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000151	0.000214	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000151	0.000213	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	0.00015	0.000211	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000144	0.000203	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	0.00014	0.000198	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	0.00014	0.000197	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	0.000134	0.000189	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	0.000133	0.000187	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000129	0.000182	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000127	0.000179	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000121	0.000171	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	0.000118	0.000167	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000116	0.000163	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	0.000113	0.00016	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	0.000112	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	0.000111	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	0.000108	0.000153	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	0.000103	0.000146	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.89e-05	0.00014	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	9.79e-05	0.000138	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	9.59e-05	0.000135	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	9.45e-05	0.000133	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	9.4e-05	0.000133	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	9.12e-05	0.000129	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	7.4e-05	0.000104	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	7.3e-05	0.000103	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	7.26e-05	0.000102	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	6.84e-05	9.65e-05	CbGpPWpGaD
